[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,901,926
  • Shares Outstanding, K 319,023
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 434 M
  • EBITDA $ 680 M
  • 60-Month Beta 1.26
  • Price/Sales 2.02
  • Price/Cash Flow 12.23
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 57.89% (-9.13%)
  • Historical Volatility 31.70%
  • IV Percentile 13%
  • IV Rank 31.95%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 21) 0.87 (4.73%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 27
  • Volume Avg (30-Day) 117
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 3,379
  • Open Int (30-Day) 2,533
  • Expected Range 17.45 to 19.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $0.15
  • Growth Rate Est. (year over year) +73.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.45 +11.37%
on 07/08/26
19.26 -4.88%
on 07/29/26
+1.01 (+5.83%)
since 06/30/26
3-Month
11.76 +55.78%
on 05/19/26
19.26 -4.88%
on 07/29/26
+5.45 (+42.35%)
since 04/30/26
52-Week
7.66 +139.01%
on 08/01/25
19.26 -4.88%
on 07/29/26
+10.25 (+127.01%)
since 07/30/25

Most Recent Stories

More News
AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX : 18.32 (-0.97%)
Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

AMRX : 18.32 (-0.97%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 18.32 (-0.97%)
Amneal Reports Second Quarter 2026 Financial Results

–  Q2 2026 Net Revenue of $796 million ; GAAP Net Income of $58 million ; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million ; Adjusted Diluted EPS of...

AMRX : 18.32 (-0.97%)
Amneal's Biosimilar Bet Gets Its First Real Report Card

Barchart Research What to Expect from AMRX Earnings AMRX Generated July 29, 2026 Current Price $19.10 EPS Estimate $$0.24 Consensus Rating Strong Buy Average Move 3.30% Amneal's Biosimilar Bet Gets Its...

AMRX : 18.32 (-0.97%)
Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

AMRX : 18.32 (-0.97%)
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

AMRX : 18.32 (-0.97%)
Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether...

AMRX : 18.32 (-0.97%)
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal’s injectable contrast portfolio Portfolio now positioned...

AMRX : 18.32 (-0.97%)
3 Reasons AMRX is Risky and 1 Stock to Buy Instead

3 Reasons AMRX is Risky and 1 Stock to Buy Instead

AMRX : 18.32 (-0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 19.04
2nd Resistance Point 18.73
1st Resistance Point 18.53
Last Price 18.32
1st Support Level 18.02
2nd Support Level 17.71
3rd Support Level 17.51

See More

52-Week High 19.26
Last Price 18.32
Fibonacci 61.8% 14.83
Fibonacci 50% 13.46
Fibonacci 38.2% 12.09
52-Week Low 7.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.